THE MIDLIFE SKIN EDITSOURCE DATES SHOWN WITH EACH REVIEW
the midlife
skin edit
Advertising disclosure: CoreAge Rx is our featured commercial partner and appears first. Placement is promotional; it is not a clinical superiority ranking. How we are funded
Hormonal-ingredient comparison

Dr. Anna Cabeca Balance Cream review

Progesterone and pregnenolone make this a hormonal-ingredient comparison. Wild-yam origin, a beauty audience and other products’ regulatory status do not turn it into an ordinary hormone-free moisturizer.

Balance Cream appears in a market where midlife skincare and broader hormone-related products can be encountered together. That proximity should not blur their differences. Dr. Anna Cabeca’s formula names progesterone and pregnenolone, which need to remain explicit before a reader interprets its botanical language or compares it with a cosmetic face cream.

The Midlife Skin Edit reviewed the official Balance product record on October 14, 2026. We did not use, prescribe or assay the cream. This article identifies the published hormonal ingredients and purchase terms, without providing a dosing schedule or assuming the product has the same purpose or regulatory status as another item from the company.

Dr. Anna Cabeca Balance Cream: Name the hormonal ingredients, Botanical origin is not hormone-free, Separate price and clinical questions
Editorial diagram of the documented facts. No product-use test or patient result is depicted.
Named hormones
Progesterone and pregnenolone; no estriol declared
Origin caveat
Wild-yam source does not mean hormone-free
Observed offer
$54.95 once / $47.26 recurring
Regulatory limit
Finished-cream FDA approval not verified
Scope
No dosing, cycle or personal treatment advice

The hormone names belong in the first comparison

The declaration names progesterone and pregnenolone, along with Tripeptide-29 and aromatic ingredients including lavender and lemongrass. Estriol is not declared. These facts make Balance distinct from both the estriol preparations and ordinary moisturizers elsewhere in the directory. Its inclusion does not imply that they are interchangeable. [1]

The product page says the preparation may influence hormone levels and advises consultation before use. That warning should not disappear behind a skin-comfort discussion. Our hormonal-ingredient guide keeps the actual substance and intended use separate from a broad midlife audience label.

Wild-yam origin does not mean hormone-free

The manufacturer describes progesterone processed from wild yam. A botanical starting material does not remove the finished ingredient’s identity as progesterone or establish that the preparation is free of hormones. It also does not demonstrate that every wild-yam skincare product has the same composition. [1]

The relevant comparison uses the current product declaration rather than a reassuring interpretation of the word natural. We do not infer systemic effects, individual safety or an appropriate amount from that origin story. Questions about the exact hormonal preparation and existing treatment belong with the responsible qualified clinician.

Another product’s status cannot be transferred here

Marketing around a company can mention products with different regulatory histories. A clearance associated with the separate Velvé lubricant does not establish approval or clearance of Balance Cream. We did not verify FDA approval of this finished cream, and the review does not describe it as an approved menopause treatment. [1]

FDA’s explanation of cosmetic labeling claims provides background on how intended claims and product categories matter. It is not a product-specific authorization. Our claims article treats brand reputation, ingredient background and the status of the actual preparation as different questions. [2]

One-time and recurring amounts describe different commitments

The captured offer displayed $54.95 for a one-time purchase and $47.26 for recurring orders, with two- or three-month choices. The lower amount should be described with its recurring condition, rather than presented as the price everyone can obtain for a single isolated purchase. [1]

The record also described US-only availability and a $6.99 priority-packing option. Packing priority is a fulfillment term, not evidence of clinical access or rapid medical advice. Actual checkout availability, shipping performance, tax and any individual eligibility requirements were not tested by this publication.

Supply and guarantee claims need their own qualifications

The seller’s sixty-day supply language and its separate description of roughly forty to fifty applications are not a usage duration verified here. This article does not reconcile them by inventing a schedule or suggesting an amount to apply. An individual plan cannot be calculated from a marketing estimate. [1]

A sixty-day guarantee is also advertised, while complete order-specific eligibility was not independently appraised. We have not opened a bottle, requested a refund or observed the handling of a claim. The guarantee should therefore remain a seller statement with conditions to confirm, rather than an assured outcome.

A skincare review cannot choose a hormonal plan

AAD’s general new-product guidance concerns skin responses and does not settle the wider questions raised by a hormonal preparation. A small skin test is not a substitute for the consultation described by the seller, nor does it establish that the cream fits an existing medical regimen. [3]

Readers can keep the product name, full declaration, intended use and order mode together when discussing it with a qualified professional. This review supplies no cycle-based instructions, dose conversion or recommendation to add hormones because of age. The midlife guide starts with the specific concern.

The meaningful finding is the category difference

Balance adds a clearly identified hormonal-ingredient record to this publication. That is a different role from simply expanding the moisturizer list. Its progesterone and pregnenolone declaration, absence of declared estriol and unresolved product-specific regulatory questions should stay visible wherever the brand is summarized.

The CoreAge Rx feature remains disclosed advertising and does not determine the conclusion. No efficacy score, medical-review credential or firsthand benefit is invented for either offering. The next useful record is the exact preparation and applicable professional advice, not a comparison built solely on botanical language or a recurring discount.

THE RESEARCH

Sources & further reading

Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.

  1. Wild Yam Cream for Menopause | Balance by Dr. Anna CabecaOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
  2. Cosmetics Labeling Claims | FDAHistorical source record; the November 14, 2026 attempt did not retrieve substantive current text. Earlier observations retain their original dates. · Checked October 14, 2026
  3. AAD: testing skincare productsGeneral cosmetic guidance rechecked November 14, 2026; this does not replace prescription instructions. · Checked November 14, 2026

Keep reading